back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-12-14 Tx date 2010-03-18 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2015-03-06 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
|
Common Shares
97 - Other
|
$47,649
+47,649,500 vol $0.001 each |
47,649,500 | |
| Filed 2017-12-14 Tx date 2015-04-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-42,884,550 vol |
4,764,950 | |
| Filed 2017-12-14 Tx date 2013-09-24 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$35,000
+35,000,000 vol $0.001 each |
37,810,000 | |
| Filed 2017-12-14 Tx date 2015-01-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$16,512,521
+165,125,212 vol $0.10 each |
202,935,212 | |
| Filed 2017-12-14 Tx date 2015-04-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-182,675,711 vol |
20,259,501 | |
| Filed 2017-12-14 Tx date 2015-04-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,800,000 vol |
200,000 | |
| Filed 2017-12-14 Tx date 2015-04-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kinwa Pharma International Company Ltd. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,800,000 vol |
200,000 | |
| Filed 2017-12-14 Tx date 2015-01-21 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-4,000
-800,000 vol $0.005 each |
800,000 | |
| Filed 2017-12-14 Tx date 2015-05-25 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-4,000
-800,000 vol $0.005 each |
0 | |
| Filed 2017-12-14 Tx date 2016-02-23 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,400,000
+2,000,000 vol $0.70 each |
2,000,000 | |
| Filed 2017-12-14 Tx date 2012-07-29 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Expiry Date July 29, 2012
55 - Expiration of warrants
|
$-2,500
-500,000 vol $0.005 each |
0 | |
| Filed 2017-12-14 Tx date 2014-07-24 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Inflexion Point Healthcare (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2015-07-31 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Holder: Inflexion Point Healthcare (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2017-12-14 Tx date 2015-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
2,000,000 | |
| Filed 2017-12-14 Tx date 2016-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Frankham, Patrick Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
4,000,000 | |
| Filed 2017-12-14 Tx date 2010-12-26 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2015-04-21 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$200,000
+2,000,000 vol $0.10 each |
2,000,000 | |
| Filed 2017-12-14 Tx date 2017-11-06 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$36,029
+92,384 vol $0.39 each |
2,092,384 | |
| Filed 2017-12-14 Tx date 2010-12-26 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2017-02-23 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+1,000,000 vol $0.70 each |
1,000,000 | |
| Filed 2017-12-14 Tx date 2015-02-05 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2015-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
2,000,000 | |
| Filed 2017-12-14 Tx date 2016-12-15 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+2,000,000 vol $0.10 each |
4,000,000 |